Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Rockefeller University discloses antibiotic peptides

Feb. 7, 1997

Another approval for first-line Abelcet

Feb. 6, 1997

Magainin analogues reported by Scripps

Feb. 6, 1997

Cephems in development at Meiji Seika

Feb. 6, 1997

Takeda discloses novel cephems

Feb. 5, 1997

U.S. patent for Tularik drug discovery assays

Feb. 4, 1997

Takeda's new cephems

Feb. 4, 1997

Novel formulation of aciclovir enters pivotal trials

Jan. 31, 1997

Micrologix receives broad patent coverage for peptide antibiotic production method

Jan. 31, 1997

Novel antiinfective agents from Tanabe

Jan. 31, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...